| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269986 | HPB | 2010 | 7 Pages |
Abstract
Valganciclovir is an effective antiviral for the prevention of CMV disease in liver transplant recipients. Our data support its use in high-risk OLT patients.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Sameh Adel Fayek, Wana Mantipisitkul, Flavia Rasetto, Raghava Munivenkatappa, Rolf N. Barth, Benjamin Philosophe,